Jason Haddock
2017
In 2017, Jason Haddock earned a total compensation of $2.4M as Chief Financial Officer at Array BioPharma.
Compensation breakdown
| Non-Equity Incentive Plan | $151,766 |
|---|---|
| Option Awards | $1,642,983 |
| Salary | $370,000 |
| Stock Awards | $154,265 |
| Other | $116,766 |
| Total | $2,435,780 |
Haddock received $1.6M in option awards, accounting for 67% of the total pay in 2017.
Haddock also received $151.8K in non-equity incentive plan, $370K in salary, $154.3K in stock awards and $116.8K in other compensation.
Rankings
In 2017, Jason Haddock's compensation ranked 4,556th out of 14,666 executives tracked by ExecPay. In other words, Haddock earned more than 68.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,556 out of 14,666 | 69th |
Division Manufacturing | 1,605 out of 5,772 | 72nd |
Major group Chemicals And Allied Products | 464 out of 2,075 | 78th |
Industry group Drugs | 357 out of 1,731 | 79th |
Industry Pharmaceutical Preparations | 284 out of 1,333 | 79th |
Source: SEC filing on September 13, 2017.
Haddock's colleagues
We found five more compensation records of executives who worked with Jason Haddock at Array BioPharma in 2017.